BMS-927711

CAS No. 1289023-67-1

BMS-927711( BMS-927711 )

Catalog No. M17925 CAS No. 1289023-67-1

BMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 107 In Stock
5MG 84 In Stock
10MG 138 In Stock
25MG 230 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BMS-927711
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
  • Description
    BMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BMS-927711
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CGRP
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1289023-67-1
  • Formula Weight
    534.56
  • Molecular Formula
    C28H28F2N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 10 mg/mL 18.71 mM; Ethanol : 10 mg/mL 18.71 mM
  • SMILES
    Fc1cccc(c1F)[C@@H]6CC[C@@H](OC(=O)N2CCC(CC2)N3c4cccnc4NC3=O)c5ncccc5[C@H]6N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DSG Crosslinker

    DSG Crosslinker is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

  • Mogroside VIB

    Mogroside VI B, a cucurbitane glucoside, separated from the crude extract of Siraitia grosvenorii. Mogroside VI B shows effect on activating PGC-1αtranscription.

  • LEM-14-1189 B

    Lem-14-1189, a LEM-14 derivative, is a potent NSD inhibitor of the nuclear receptor binding SET domain, and has inhibitory effects on NSD1, NSD2, and NSD3, with IC50 of 418 μM, 111 μM, and 60 μM, respectively.